Filing Details
- Accession Number:
- 0001209191-18-015306
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-01 20:50:13
- Reporting Period:
- 2018-02-28
- Accepted Time:
- 2018-03-01 20:50:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1180262 | Herbalife Ltd. | HLF | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1624298 | Jossie Aspauza | 800 W. Oympic Blvd. Suite 406 Los Angeles CA 90015 | Vp, Sam/Cam | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-02-28 | 2,512 | $79.58 | 14,592 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-02-28 | 2,171 | $92.10 | 12,421 | No | 4 | D | Direct | |
Common Stock | Disposition | 2018-02-28 | 103 | $92.10 | 12,318 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2018-02-28 | 3,752 | $59.98 | 16,070 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-02-28 | 2,444 | $92.10 | 13,626 | No | 4 | D | Direct | |
Common Stock | Disposition | 2018-02-28 | 393 | $92.10 | 13,233 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2018-02-28 | 1,048 | $62.51 | 14,281 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-02-28 | 712 | $92.10 | 13,569 | No | 4 | D | Direct | |
Common Stock | Disposition | 2018-02-28 | 102 | $92.10 | 13,467 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2018-02-28 | 1,102 | $57.19 | 14,569 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-02-28 | 685 | $92.10 | 13,884 | No | 4 | D | Direct | |
Common Stock | Disposition | 2018-02-28 | 126 | $92.10 | 13,758 | No | 4 | F | Direct | |
Common Stock | Disposition | 2018-02-28 | 9,995 | $90.38 | 3,763 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | D | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | D | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | D | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | D | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Appreciation Rights | Disposition | 2018-02-28 | 2,512 | $0.00 | 2,512 | $79.58 |
Common Stock | Stock Appreciation Rights | Disposition | 2018-02-28 | 3,752 | $0.00 | 3,752 | $59.98 |
Common Stock | Stock Appreciation Rights | Disposition | 2018-02-28 | 1,048 | $0.00 | 1,048 | $62.51 |
Common Stock | Stock Appreciation Rights | Disposition | 2018-02-28 | 1,102 | $0.00 | 1,102 | $57.19 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2016-06-21 | 2023-12-19 | No | 4 | M | Direct |
0 | 2017-04-30 | 2024-04-30 | No | 4 | M | Direct |
4,192 | 2017-05-09 | 2026-05-09 | No | 4 | M | Direct |
4,406 | 2018-02-27 | 2027-02-27 | No | 4 | M | Direct |
Footnotes
- The reporting person received 238 shares of common stock upon the net exercise of 2,512 stock appreciation rights ("SARs"). The reporting person forfeited 2,171 shares of common stock underlying the SARs in payment of the exercise price and 103 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
- The reporting person received 915 shares of common stock upon the net exercise of 3,752 SARs. The reporting person forfeited 2,444 shares of common stock underlying the SARs in payment of the exercise price and 393 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
- The reporting person received 234 shares of common stock upon the net exercise of 1,048 SARs. The reporting person forfeited 712 shares of common stock underlying the SARs in payment of the exercise price and 102 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
- The reporting person received 291 shares of common stock upon the net exercise of 1,102 SARs The reporting person forfeited 685 shares of common stock underlying the SARs in payment of the exercise price and 126 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
- This transaction was executed in multiple trades at prices ranging from $90.11 to $90.65. The price reported reflects the weighted average sale price of $90.38. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Consists of stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested May 9, 2017, and 20% will vest on May 9, 2018, and the remaining 60% will vest May 9, 2019.
- Consists of stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested February 27, 2018, 20% will vest February 27, 2019, and the remaining 60% will vest February 27, 2020.